[go: up one dir, main page]

PL414619A1 - Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy - Google Patents

Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy

Info

Publication number
PL414619A1
PL414619A1 PL414619A PL41461915A PL414619A1 PL 414619 A1 PL414619 A1 PL 414619A1 PL 414619 A PL414619 A PL 414619A PL 41461915 A PL41461915 A PL 41461915A PL 414619 A1 PL414619 A1 PL 414619A1
Authority
PL
Poland
Prior art keywords
borysthenica
gruner
centaurea
herb
extract
Prior art date
Application number
PL414619A
Other languages
Polish (pl)
Other versions
PL232119B1 (en
Inventor
Agnieszka Korga
Aleksandra Józefczyk
Grażyna Zgórka
Jarosław Dudka
Original Assignee
Uniwersytet Medyczny W Lublinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL414619A priority Critical patent/PL232119B1/en
Publication of PL414619A1 publication Critical patent/PL414619A1/en
Publication of PL232119B1 publication Critical patent/PL232119B1/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowe zastosowanie ekstraktu z ziela Centaurea borysthenica (Gruner) do leczenia kardioprotekcyjnego u pacjentów leczonych lekami z grupy antracyklin.The subject of the application is a new use of the Centaurea borysthenica herb extract (Gruner) for cardioprotective treatment in patients treated with anthracyclines.

PL414619A 2015-10-29 2015-10-29 Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy PL232119B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL414619A PL232119B1 (en) 2015-10-29 2015-10-29 Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL414619A PL232119B1 (en) 2015-10-29 2015-10-29 Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy

Publications (2)

Publication Number Publication Date
PL414619A1 true PL414619A1 (en) 2017-05-08
PL232119B1 PL232119B1 (en) 2019-05-31

Family

ID=58643826

Family Applications (1)

Application Number Title Priority Date Filing Date
PL414619A PL232119B1 (en) 2015-10-29 2015-10-29 Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy

Country Status (1)

Country Link
PL (1) PL232119B1 (en)

Also Published As

Publication number Publication date
PL232119B1 (en) 2019-05-31

Similar Documents

Publication Publication Date Title
CL2017003006A1 (en) Methods of conditioning patients for treatment with T lymphocytes
MX2023000796A (en) PHARMACEUTICAL COMPOSITION, METHODS FOR TREATMENT AND ITS USES.
DOP2017000272A (en) METHODS OF DIAGNOSIS FOR TREATMENT WITH LYMPHOCYTES T
MX378273B (en) ACTIVE COMPOUNDS TOWARDS BROMODOMAINS.
PL3896064T3 (en) 4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS COT MODULATORS IN THE TREATMENT OF CROOHN'S DISEASE AND ULTRASPECTRUM COLITIS
DK3377637T3 (en) COMPOSITIONS FOR USE IN PROCEDURES FOR TREATMENT OF SKIN SCREWS, DISEASES AND DISEASES
WO2016025635A3 (en) Combination therapy for treating cancer
MX2022008868A (en) Treatment of cancer with tg02.
WO2016043874A3 (en) Combination therapy for treating cancer
MX2017002489A (en) Human therapeutic agents.
MX2016015378A (en) Use of eribulin in the treatment of cancer.
MX379359B (en) DERIVATIVES OF 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECane.
GEP20186939B (en) Medical treatments based on anamorelin
MA50358A (en) SEMAGLUTIDE IN MEDICAL THERAPY
MX379201B (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
ZA201708686B (en) Nanoparticles for use as a therapeutic vaccine
CY1119532T1 (en) (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
TW201713323A (en) Therapeutic compositions and methods of use thereof
MX2017013047A (en) Treatment of pain.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EA201700254A1 (en) COMBINATION
PL414619A1 (en) Medical application of the extract from Centaurea borysthenica Gruner herb in cardioprotective therapy
PL414618A1 (en) Medical application of the extract from Centaurea daghestanica (Lipsky) Wagenitz herb in cardioprotective therapy
IL268265B (en) 3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment
BR112017012931A2 (en) methods for reducing platelet aggregation and treating cardiovascular disease and other medical disorders